Explore our materials

Spanish HIV Clinical Forum 2018

Interstitial pneumonia by triple viral co-infection in a CDC C2 HIV- infected patient- Carme Bracke

Jose Arribas

Spanish HIV Clinical Forum 2018

Optimizing Clinical Care- José Arribas, MD

Spanish HIV Clinical Forum 2018

Raltegravir plus abacavir/lamivudine in virologically suppressed HIV-1-infected patients: 48-week results of the KIRAL study- Jésus Troya

Spanish HIV Clinical Forum 2018

State of the ART: Integrase Inhibitors Clinical Data- Juan Berenguer, MD

JML

Josep M. Llibre

MD, PhD

Spanish HIV Clinical Forum 2018

What is the Virological support for reduced drug regimens?- Josep Llibre, MD, PhD

Mark Nelson

MD, MBBS, FRCP

International Conference on (Re-) Emerging Infectious Diseases (ICREID) 2018

Debate: Can we eliminate HCV from Africa? | Mark Nelson, MD

Richard Njouom

PhD, HDR

International Conference on (Re-) Emerging Infectious Diseases (ICREID) 2018

Debate: Can we eliminate HCV from Africa? | Richard Njouom, PhD

International Conference on (Re-) Emerging Infectious Diseases (ICREID) 2018

The new epidemic of drug resistant HIV-1 | Gillian Hunt, PhD

International Conference on (Re-) Emerging Infectious Diseases (ICREID) 2018

ALERRT - The African coaLition for Epidemic Research, Response and Training | Peter Horby, MD, PhD

International Conference on (Re-) Emerging Infectious Diseases (ICREID) 2018

PANDORA-ID-NET | Francine Ntoumi, PhD

International Conference on (Re-) Emerging Infectious Diseases (ICREID) 2018

Rise and spread of multi-drug resistant malaria | Francine Ntoumi, PhD